罗氏万赛维多少钱一盒？

(Valganciclovir Hydrochloride Tablets) is a prodrug of the antiviral drug ganciclovir developed by the Swiss company Roche. It was approved by the U.S. FDA in March 2001 and was first launched in the United States in May 2001. It is the first oral drug to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). In May 2003, its indications were expanded to prevent and treat secondary complications in organ transplant recipients. CMV infection. So, how much does a box of Roche Vancevir cost?

Although Roche's Vancevir has been on the market in China for 14 years, it has not yet been included in the scope of medical insurance, so patients currently have to pay for the drug at their own expense. In China, a box of 450mg*60 tablets of Vancevir costs about $17,000, which is a considerable financial burden for patients. In order to reduce the burden, patients can obtain more cost-effective drugs from overseas through medical companion travel. It is reported that a box of the Turkish version of Vancevi is priced at around $3,000, and the drug specifications are also 450mg*60 tablets/box, so the price/performance ratio is relatively high.

In order to improve the compliance of pediatric patients, Roche has previously announced that the U.S. FDA has approved the marketing of a new children's oral solution of valganciclovir hydrochloride Valcyte for the prevention of CMV disease in children and adolescent patients aged 4 months to 16 years old who are at high risk for kidney and heart transplantation.

The Roche Group has the unique position of being the only innovation leader in the medical industry covering the fields of diagnosis and pharmaceuticals. It is the TOP1 global pharmaceutical company. Founded in 1896 and headquartered in Basel, Switzerland, it is a pioneer in global pharmaceuticals and diagnostics. The prices developed and produced by Roche vary from place to place, and patients can choose to purchase according to their needs.

Recommended hot articles: /newsDetail/90774.html